Ester Falconer's most recent trade in AbCellera Biologics Inc was a trade of 875,000 Common Shares done at an average price of $16.9 . Disclosure was reported to the exchange on Sept. 1, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc | Ester Falconer | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.89 per share. | 01 Sep 2021 | 875,000 | 875,000 | - | 16.9 | 14,778,750 | Common Shares |
| AbCellera Biologics Inc | Ester Falconer | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 875,000 | 875,000 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Ester Falconer | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 25.50 per share. | 09 Jun 2021 | 1,000,000 | 0 | - | 25.5 | 25,500,000 | Common Shares |